In London Researchers discover new way to fight cancer

Researchers may have found a way to build the body’s immune system, potentially enabling it to fight off any kind of cancer or virus.

  • Published:
Researchers at Imperial College London have designed a new self-assembling nanoparticle that targets tumors, helping doctors diagnose cancer earlier. play

Researchers at Imperial College London have designed a new self-assembling nanoparticle that targets tumors, helping doctors diagnose cancer earlier.

(Scitech Daily)
24/7 Live - Subscribe to the Pulse Newsletter!

A “completely unknown” protein was discovered by scientists at Imperial College London, and they hope to begin trials on a new genetic therapy on humans in three years, Daily Telegraph reports.

The immune system tries to fight cancer with T cells but usually loses the battle. However the protein, called Lymphocyte Expansion Molecule (LEM), enables a much larger number of T cells to be produced – enough to overwhelm cancer or other kinds of diseases.

A professor at Imperial, Philip Ashton-Rickardt, who led the study published in the Journal Science, said: “This is exciting because we have found a completely different way to use the immune system to fight cancer.

“It could be a game-changer for treating a number of different cancers and viruses.

“This is a completely unknown protein. Nobody had ever seen it before or was even aware that it existed. It looks and acts like no other protein.”

The protein was found while Mice with genetic mutations were being screened. Mice with a particular mutation produced 10 times the number of T cells and this was linked to the protein, which is also present in humans.

A senior science information officer at Cancer Research UK, Dr Alan Worsley, said: “This exciting work in mice is still at an early stage and only looked at one type of cancer.

“Cancer often finds a way to suppress the immune system, but drugs that overcome this and allow immune cells to target cancer show great promise.

“The researchers now need to figure out how to develop drugs that target this molecule, and whether doing so would be safe and effective in cancer patients,” he added.

Do you ever witness news or have a story that should be featured on Pulse Nigeria?
Submit your stories, pictures and videos to us now via WhatsApp: +2349055172167, Social Media @pulsenigeria247: #PulseEyewitness & DM or Email: eyewitness@pulse.ng. More information here.